1 Shanmugam VB, Harper R, Meredith I, Malaiapan Y, Psaltis PJ. An overview of PCI in the very elderly. J Geriatr Cardiol.2015; 12:174-184.
2 Vandermolen S, Abbott J, De Silva K. What's Age Got to do with it? A Review of Contemporary Revascularization in the Elderly. Curr Cardiol Rev 2015;11:199-208.
3 Ye Y, Xie H, Zeng Y, Zhao X, Tian Z, Zhang S, et al. Association between subclinical hypothyroidism and blood pressure-a meta-analysis of observational studies. Endocr Pract 2014;20:150-158.
4 Pearce EN.Update in lipid alterations in subclinical hypothyroidism. J Clin Endocrinol Metab2012;97:326-333.
5 Mitsuru Masaki, Kazuo Komamura, Akiko Goda, Shinichi Hirotani, Misato Otsuka, Ayumi Nakabo, et al. Elevated arterial stiffness and diastolic dysfunction in subclinical hypothyroidism. J Circulation journal: official journal of the Japanese Circulation Society 2014; 78(6):1494-1500.
6 Razvi S, Weaver JU, Pearce SH. Subclinical thyroid disorders: significance and clinical impact. J Clin Pathol 2010;63:379-386.
7 Biondi B , Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008;29:76-131.
8 Marfella R, Ferraraccio F, Rizzo MR, Portoghese M, Barbieri M, Basilio C, et al. Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism. J Clin Endocrinol Metab 2011 Apr;96:1015-1020.
9 Floriani C, Gencer B, Collet TH, Rodondi N. Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update. Eur Heart J 2017; 39(7):503-507.
10 Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frölich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004; 292:2591-2599.
11 Grossman A, Weiss A, Koren-Morag N, Shimon I, Beloosesky Y, Meyerovitch J. Subclinical Thyroid Disease and Mortality in the Elderly: A Retrospective Cohort Study. Am J Med 2016;129:423-430.
12 Hyland KA, Arnold AM, Lee JS, Cappola AR. Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the Cardiovascular Health Study. J Clin Endocrinol Metab 2013; 98:533-540.
13 Waring AC, Harrison S, Samuels MH, Ensrud KE, LeBlanc ES, Hoffman AR, et al. Osteoporotic Fractures in Men (MrOS) Study. Thyroid function and mortality in older men: a prospective study. J Clin Endocrinol Metab 2012; 97:862-870.
14 Pearce SHS, Razvi S, Yadegarfar ME, Martin-Ruiz C, Kingston A, Collerton J, et al. Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study. J Clin Endocrinol Metab 2016; 101: 4385-4394.
15 Suh S, Kim DK. Subclinical Hypothyroidism and Cardiovascular Disease. Endocrinol Metab (Seoul)2015; 30:246-251.
16 Sun J, Yao L, Fang Y, Yang R, Chen Y, Yang K, et al. Relationship between Subclinical Thyroid Dysfunction and the Risk of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. Int J Endocrinol 2017; doi: 10.1155/2017/8130796.
17 Iervasi G, Molinaro S, Landi P, Taddei MC, Galli E, Mariani F, et al. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch Intern Med2007; 167:1526-1532.
18. Molinaro S, Iervasi G, Lorenzoni V, Coceani M, Landi P, Srebot V, et al. Persistence of mortality risk in patients with acute cardiac diseases and mild thyroid dysfunction. Am J Med Sci 2012; 343:65-70.
19 Zhang M, Sara JD, Matsuzawa Y, Gharib H, Bell MR, Gulati R, et al. Clinical outcomes of patients with hypothyroidism undergoing percutaneous coronary intervention. Eur Heart J 2016; 37:2055-2065.
20 Lee Y, Lim YH, Shin JH, Park J, Shin J. Impact of subclinical hypothyroidism on clinical outcomes following percutaneous coronary intervention. Int J Cardiol 2018; 253:155-160.
21 Razvi S, Shakoor A, VanderpumpM, Weaver JU, Pearce SHS. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a meta- analysis. J Clin EndocrinolMetab 2008; 93:2998-3007.
22 Kim TH, Choi HS, Bae JC, Moon JH, Kim HK, Choi SH, et al. Subclinical hypothyroidism in addition to common risk scores for prediction of cardiovascular disease: a 10-year community-based cohort study. Eur J Endocrinol2014; 171:649-657.
23 Kovar FM, Fang IF, Perkmann T, Haslacher H, Slavka G, Födinger M, et al. Subclinical hypothyroidism and mortality in a large Austrian cohort: a possible impact on treatment? Wien Klin Wochenschr 2015;127:924-930.
24 Andersen MN, Olsen AS, Madsen JC, Kristensen SL, Faber J, Torp-Pedersen C, et al. Long-Term Outcome in Levothyroxine Treated Patients With Subclinical Hypothyroidism and Concomitant Heart Disease. J Clin Endocrinol Metab 2016; 101:4170-4177.
25 Shah R. In older adults with subclinical hypothyroidism, levothyroxine did not improve symptoms or tiredness. Ann Intern Med 2017; 167:JC14.
26 Grossman A, Feldhamer I, Meyerovitch J. Treatment with levothyroxin in subclinical hypothyroidism is associated with increased mortality in the elderly. Eur J Intern Med 2018; doi: 10.1016/j.ejim.2017.11.010.
27Jabbar A, Ingoe L, Pearce S, Zaman A, Razvi S.Thyroxine in acute myocardial infarction (ThyrAMI)-levothyroxine in subclinical hypothyroidismpost-acute myocardial infarction: study protocol for a randomised controlled trial. Trials 2015;doi: 10.1186/s13063-015-0621-5.